UnitedHealth Group Incorporated $UNH Shares Sold by High Note Wealth LLC

Key Points

• High Note Wealth LLC reduced its stake in UnitedHealth Group by 63.5%, selling 9,426 shares to hold 5,415 shares valued at $1,689,000.
• UnitedHealth's annual dividend was recently declared at $2.21 per share, resulting in a yield of 2.5% and a dividend payout ratio of 38.30%.
• Despite a quarterly earnings miss, with EPS of $4.08 against an expected $4.45, the company reported a revenue growth of 12.9% year-over-year.

High Note Wealth LLC lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 63.5% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,415 shares of the healthcare conglomerate's stock after selling 9,426 shares during the period. High Note Wealth LLC's holdings in UnitedHealth Group were worth $1,689,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in UNH. Nuveen LLC acquired a new position in UnitedHealth Group during the 1st quarter worth approximately $3,846,764,000. Vanguard Group Inc. grew its holdings in UnitedHealth Group by 6.6% during the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after acquiring an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP grew its holdings in UnitedHealth Group by 10.6% during the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock worth $13,537,859,000 after acquiring an additional 2,486,839 shares in the last quarter. National Bank of Canada FI boosted its holdings in shares of UnitedHealth Group by 137.8% in the 1st quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate's stock valued at $859,518,000 after buying an additional 950,928 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of UnitedHealth Group by 13.6% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate's stock valued at $3,702,736,000 after buying an additional 847,054 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Stock Down 0.3%

Shares of UnitedHealth Group stock opened at $358.95 on Tuesday. The company has a market cap of $325.09 billion, a P/E ratio of 15.55, a PEG ratio of 2.34 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The firm has a fifty day moving average of $309.38 and a two-hundred day moving average of $352.34.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm's quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were given a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group's dividend payout ratio is presently 38.30%.

Analyst Ratings Changes

Several research analysts have recently issued reports on UNH shares. KeyCorp lowered their target price on shares of UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a report on Wednesday, July 30th. Robert W. Baird restated an "underperform" rating and issued a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Piper Sandler lowered their target price on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a report on Wednesday, July 30th. Wells Fargo & Company reduced their price target on shares of UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating for the company in a research report on Monday, August 4th. Finally, Sanford C. Bernstein upped their price target on shares of UnitedHealth Group from $337.00 to $379.00 and gave the company an "outperform" rating in a research report on Friday, September 5th. Sixteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and four have issued a Sell rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $358.95.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.